Cargando…

Clinical outcome of transthoracic esophagectomy with thoracic duct resection: Number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct

The number of dissected lymph nodes (LNs), surgical outcomes, and postoperative recurrence-free survival (RFS) were compared between thoracic duct (TD)-preserved and TD-resected groups. The distribution of metastasis in LNs around TD (TDLN) was reviewed. Transthoracic esophagectomy (TTE) with TD res...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuda, Satoru, Takeuchi, Hiroya, Kawakubo, Hirofumi, Shimada, Ayako, Fukuda, Kazumasa, Nakamura, Rieko, Takahashi, Tsunehiro, Wada, Norihito, Kameyama, Kaori, Kitagawa, Yuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998447/
https://www.ncbi.nlm.nih.gov/pubmed/27310961
http://dx.doi.org/10.1097/MD.0000000000003839
_version_ 1782449944624365568
author Matsuda, Satoru
Takeuchi, Hiroya
Kawakubo, Hirofumi
Shimada, Ayako
Fukuda, Kazumasa
Nakamura, Rieko
Takahashi, Tsunehiro
Wada, Norihito
Kameyama, Kaori
Kitagawa, Yuko
author_facet Matsuda, Satoru
Takeuchi, Hiroya
Kawakubo, Hirofumi
Shimada, Ayako
Fukuda, Kazumasa
Nakamura, Rieko
Takahashi, Tsunehiro
Wada, Norihito
Kameyama, Kaori
Kitagawa, Yuko
author_sort Matsuda, Satoru
collection PubMed
description The number of dissected lymph nodes (LNs), surgical outcomes, and postoperative recurrence-free survival (RFS) were compared between thoracic duct (TD)-preserved and TD-resected groups. The distribution of metastasis in LNs around TD (TDLN) was reviewed. Transthoracic esophagectomy (TTE) with TD resection for esophageal cancer patients has been one of the standard procedures. Because the adipose tissue surrounding the TD contains LNs, TD resection might be necessary for radical LN dissection. However, few studies have investigated the oncological outcome of TTE with TD resection. Two hundred fifty-six consecutive patients who underwent TTE between 2004 and 2015 were retrospectively reviewed and classified into TD-preserved or TD-resected groups. The number of dissected LNs for each LN station and surgical outcomes were compared. RFS was analyzed in 155 patients who underwent TTE before December 2012. Since 2013, the TDLN number was prospectively examined, independent of the regional LNs (n = 72). Of these, the TDLN number for each location (TDLN-Ut/Mt/Lt) was investigated and the correlation between TDLN metastasis and clinicopathological factors was analyzed. The TD was preserved in 89 patients and resected in 167 patients. Patients with TD resection showed significant advanced stage. There was no significant difference in the incidence of postoperative complications, including pneumonia, anastomotic leakage, and chylothorax. The number of dissected mediastinal LNs was significantly increased in the TD-resected group. The 5-year RFS rate of cStage I patients was 67.3% in the TD-preserved group against 90.3% in the TD-resected group, showing a tendency towards RFS extension that did not quite reach statistical significance (P = 0.055). The mean TDLN-Ut/Mt/Lt numbers were 0.89/0.56/0.44, respectively. Eight of 72 (11%) patients displayed TDLN metastasis. Metastatic TDLNs were observed on the same or cranial level of the primary lesion in 7 of 8 patients. Transthoracic esophagectomy with TD resection could increase the number of dissected mediastinal LNs without increase of postoperative complication. TDLN metastasis was observed in patients with advanced disease. A prospective trial, investigating the survival between TD-preserved and TD-resected groups, should be conducted to clarify if TD should be resected in TTE.
format Online
Article
Text
id pubmed-4998447
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-49984472016-09-02 Clinical outcome of transthoracic esophagectomy with thoracic duct resection: Number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct Matsuda, Satoru Takeuchi, Hiroya Kawakubo, Hirofumi Shimada, Ayako Fukuda, Kazumasa Nakamura, Rieko Takahashi, Tsunehiro Wada, Norihito Kameyama, Kaori Kitagawa, Yuko Medicine (Baltimore) 7100 The number of dissected lymph nodes (LNs), surgical outcomes, and postoperative recurrence-free survival (RFS) were compared between thoracic duct (TD)-preserved and TD-resected groups. The distribution of metastasis in LNs around TD (TDLN) was reviewed. Transthoracic esophagectomy (TTE) with TD resection for esophageal cancer patients has been one of the standard procedures. Because the adipose tissue surrounding the TD contains LNs, TD resection might be necessary for radical LN dissection. However, few studies have investigated the oncological outcome of TTE with TD resection. Two hundred fifty-six consecutive patients who underwent TTE between 2004 and 2015 were retrospectively reviewed and classified into TD-preserved or TD-resected groups. The number of dissected LNs for each LN station and surgical outcomes were compared. RFS was analyzed in 155 patients who underwent TTE before December 2012. Since 2013, the TDLN number was prospectively examined, independent of the regional LNs (n = 72). Of these, the TDLN number for each location (TDLN-Ut/Mt/Lt) was investigated and the correlation between TDLN metastasis and clinicopathological factors was analyzed. The TD was preserved in 89 patients and resected in 167 patients. Patients with TD resection showed significant advanced stage. There was no significant difference in the incidence of postoperative complications, including pneumonia, anastomotic leakage, and chylothorax. The number of dissected mediastinal LNs was significantly increased in the TD-resected group. The 5-year RFS rate of cStage I patients was 67.3% in the TD-preserved group against 90.3% in the TD-resected group, showing a tendency towards RFS extension that did not quite reach statistical significance (P = 0.055). The mean TDLN-Ut/Mt/Lt numbers were 0.89/0.56/0.44, respectively. Eight of 72 (11%) patients displayed TDLN metastasis. Metastatic TDLNs were observed on the same or cranial level of the primary lesion in 7 of 8 patients. Transthoracic esophagectomy with TD resection could increase the number of dissected mediastinal LNs without increase of postoperative complication. TDLN metastasis was observed in patients with advanced disease. A prospective trial, investigating the survival between TD-preserved and TD-resected groups, should be conducted to clarify if TD should be resected in TTE. Wolters Kluwer Health 2016-06-17 /pmc/articles/PMC4998447/ /pubmed/27310961 http://dx.doi.org/10.1097/MD.0000000000003839 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle 7100
Matsuda, Satoru
Takeuchi, Hiroya
Kawakubo, Hirofumi
Shimada, Ayako
Fukuda, Kazumasa
Nakamura, Rieko
Takahashi, Tsunehiro
Wada, Norihito
Kameyama, Kaori
Kitagawa, Yuko
Clinical outcome of transthoracic esophagectomy with thoracic duct resection: Number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct
title Clinical outcome of transthoracic esophagectomy with thoracic duct resection: Number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct
title_full Clinical outcome of transthoracic esophagectomy with thoracic duct resection: Number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct
title_fullStr Clinical outcome of transthoracic esophagectomy with thoracic duct resection: Number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct
title_full_unstemmed Clinical outcome of transthoracic esophagectomy with thoracic duct resection: Number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct
title_short Clinical outcome of transthoracic esophagectomy with thoracic duct resection: Number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct
title_sort clinical outcome of transthoracic esophagectomy with thoracic duct resection: number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct
topic 7100
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998447/
https://www.ncbi.nlm.nih.gov/pubmed/27310961
http://dx.doi.org/10.1097/MD.0000000000003839
work_keys_str_mv AT matsudasatoru clinicaloutcomeoftransthoracicesophagectomywiththoracicductresectionnumberofdissectedlymphnodeanddistributionoflymphnodemetastasisaroundthethoracicduct
AT takeuchihiroya clinicaloutcomeoftransthoracicesophagectomywiththoracicductresectionnumberofdissectedlymphnodeanddistributionoflymphnodemetastasisaroundthethoracicduct
AT kawakubohirofumi clinicaloutcomeoftransthoracicesophagectomywiththoracicductresectionnumberofdissectedlymphnodeanddistributionoflymphnodemetastasisaroundthethoracicduct
AT shimadaayako clinicaloutcomeoftransthoracicesophagectomywiththoracicductresectionnumberofdissectedlymphnodeanddistributionoflymphnodemetastasisaroundthethoracicduct
AT fukudakazumasa clinicaloutcomeoftransthoracicesophagectomywiththoracicductresectionnumberofdissectedlymphnodeanddistributionoflymphnodemetastasisaroundthethoracicduct
AT nakamurarieko clinicaloutcomeoftransthoracicesophagectomywiththoracicductresectionnumberofdissectedlymphnodeanddistributionoflymphnodemetastasisaroundthethoracicduct
AT takahashitsunehiro clinicaloutcomeoftransthoracicesophagectomywiththoracicductresectionnumberofdissectedlymphnodeanddistributionoflymphnodemetastasisaroundthethoracicduct
AT wadanorihito clinicaloutcomeoftransthoracicesophagectomywiththoracicductresectionnumberofdissectedlymphnodeanddistributionoflymphnodemetastasisaroundthethoracicduct
AT kameyamakaori clinicaloutcomeoftransthoracicesophagectomywiththoracicductresectionnumberofdissectedlymphnodeanddistributionoflymphnodemetastasisaroundthethoracicduct
AT kitagawayuko clinicaloutcomeoftransthoracicesophagectomywiththoracicductresectionnumberofdissectedlymphnodeanddistributionoflymphnodemetastasisaroundthethoracicduct